Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors

被引:30
作者
Lee, YC
Juan, CC
Fang, VS
Hsu, YP
Lin, SH
Kwok, CF
Ho, LT
机构
[1] Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
[2] Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1998年 / 47卷 / 12期
关键词
D O I
10.1016/S0026-0495(98)90071-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The specificity of endothelin (ET) receptors involved in the inhibition of insulin-stimulated glucose uptake ([SGU) in rat adipocytes was investigated. Adipocytes were isolated from the epididymal fat pads of Sprague-Dawley rats. To determine receptor subtypes, we used three ET isopeptides, ET-1 and ET-2, both of which are nonselective agonists, and ET-3, a selective agonist for ETc receptors, to displace [I-125]]ET-1 binding from the fat cells. The efficiency of displacement was ET-1 > ET-2 much greater than ET-3, indicating that the primary receptors involved belonged to the ETA subtype. At an equal concentration of 1 mu mol/L, BQ-610, a selective ETA antagonist, displaced [I-125]ET-1 from binding to far cells, whereas IRL-1038, a selective ETB antagonist, did not. Using [H-3]2-deoxy-D-1-glucose ([H-3]2-DG) as a tracer in studies of glucose uptake, we found that equimolar BQ-610 completely reversed the inhibitory effect of ET-1 on ISGU, whereas IRL-1038 was ineffective. Northern blot analysis of adipocyte receptors showed abundant mRNA for ETA, but no ETB subtype. These results clearly demonstrate that ETA is the predominant receptor in rat adipocytes. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:1468 / 1471
页数:4
相关论文
共 24 条
[1]   THE CURRENT ENDOTHELIN RECEPTOR CLASSIFICATION - TIME FOR RECONSIDERATION [J].
BAX, WA ;
SAXENA, PR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (10) :379-386
[2]  
BEGUM N, 1993, J BIOL CHEM, V268, P3352
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   ENDOTHELIN-1 INHIBITS INSULIN-STIMULATION GLUCOSE-UPTAKE IN ISOLATED RAT ADIPOCYTES [J].
CHOU, YC ;
PERNG, JC ;
JUAN, CC ;
JANG, SY ;
KWOK, CF ;
CHEN, WL ;
FONG, JC ;
HO, LT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (02) :688-693
[5]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[6]   CIRCULATING ENDOTHELIN-1 LEVELS INCREASE DURING EUGLYCEMIC HYPERINSULINEMIC CLAMP IN LEAN NIDDM MEN [J].
FERRI, C ;
CARLOMAGNO, A ;
COASSIN, S ;
BALDONCINI, R ;
FALDETTA, MRC ;
LAURENTI, O ;
PROPERZI, G ;
SANTUCCI, A ;
DEMATTIA, G .
DIABETES CARE, 1995, 18 (02) :226-233
[7]   PLASMA ENDOTHELIN-1 LEVELS IN OBESE HYPERTENSIVE AND NORMOTENSIVE MEN [J].
FERRI, C ;
BELLINI, C ;
DESIDERI, G ;
DIFRANCESCO, L ;
BALDONCINI, R ;
SANTUCCI, A ;
DEMATTIA, G .
DIABETES, 1995, 44 (04) :431-436
[8]  
GARVEY WT, 1987, J BIOL CHEM, V262, P189
[9]   ENDOTHELIN IS A POTENT MITOGEN FOR RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
HIRATA, Y ;
TAKAGI, Y ;
FUKUDA, Y ;
MARUMO, F .
ATHEROSCLEROSIS, 1989, 78 (2-3) :225-228
[10]   Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation [J].
Huang, YJ ;
Fang, VS ;
Juan, CC ;
Chou, YC ;
Kwok, CF ;
Ho, LT .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (11) :1252-1258